1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
AI Financial Corporation received a Nasdaq notice on July 1, 2026, that its common stock has traded below the $1.00 minimum closing bid price for 30 consecutive business days. The notice has no immediate effect on trading, and the stock continues to trade on the Nasdaq Capital Market as AIFC, but the company must regain compliance or face possible delisting.
Nasdaq notified the company on July 1, 2026; June 30, 2026 was the 30th consecutive day below $1.00
Compliance period runs 180 calendar days, until December 28, 2026, requiring at least 10 consecutive business days at or above $1.00
If not compliant by then, Nasdaq may grant a second 180-day period; otherwise delisting determination with right to appeal to a Hearings Panel
Company may consider options including a reverse stock split
HeartBeam, Inc. received a Nasdaq notice on June 30, 2026, saying its common stock has closed below the $1.00 minimum bid price for 30 consecutive business days. The notice has no immediate effect on the listing, but the company must regain compliance by December 28, 2026, or face possible delisting.
Nasdaq letter dated June 30, 2026 cites non-compliance with the $1.00 minimum bid price under Listing Rule 5550(a)(2)
Company has a 180 calendar day compliance period, until December 28, 2026, to show a closing bid of at least $1.00 for ten consecutive business days
A second 180-day period may be available if the company meets market value and other initial listing standards, and the company says it cannot assure it will regain compliance
Navient disclosed a material cybersecurity incident in which a ransomware attack on a third-party law firm led to unauthorized access to Company-related borrower data, including names, dates of birth, addresses and Social Security numbers. The company says its own systems were not accessed and operations were not disrupted, and it does not believe the incident has had or is reasonably likely to have a material impact on its financial condition or results.
Company became aware of the incident on June 8, 2026, and determined it material on June 29, 2026
Exposed data includes borrower names, dates of birth, addresses and Social Security numbers
Incident was limited to the law firm's environment; no evidence of access to Navient systems and no operational disruption
Notifications to affected individuals and regulators are underway; law enforcement has been notified
AdaptHealth said a threat actor gained unauthorized access to certain cloud-based business applications, including patient management and document storage systems, and exfiltrated some data. The company determined on June 27, 2026 that the incident is material, and said it has contained the threat and that operations and patient service have not been materially affected. The full financial impact, data scope and volume remain undetermined, and the company says cybersecurity insurance may cover some losses.
Threat actor contacted the company on June 15, 2026, claiming to have obtained data from its systems
Affected data includes insurance billing passwords and certain patient personally identifiable and protected health information
Company does not collect Social Security numbers or store financial account or payment card data in the affected systems
Company says it cannot yet determine the full financial impact and will amend the filing as information becomes available
On July 1, 2026, the Centers for Medicare & Medicaid Services withdrew billing and fee schedule changes that followed the FDA's April 16, 2026 reclassification of non-invasive bone growth stimulators. Orthofix now expects average Medicare reimbursement for the affected codes to return to the rates in effect before May 18, 2026. The filing gives no dollar figures for the expected impact.
FDA final order on April 16, 2026 reclassified non-invasive bone growth stimulators from Class III to Class II devices.
CMS changes to billing and Medicare fee schedule treatment applied to HCPCS codes E0747, E0748 and E0760 for dates of service on or after May 18, 2026.
On July 1, 2026, CMS withdrew those changes and directed that devices furnished on or after May 18, 2026 be paid as before the reclassification.
Orthofix expects average Medicare reimbursement for these codes to return to pre-May 18, 2026 rates; no dollar amounts were disclosed.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.